top of page
GBX EVENTS Logo
CGTI.png

8th Annual Cell & Gene Therapy Innovation Leaders Summit 2025

10th & 11th September 2025
Hyatt Regency Barcelona Tower, Spain

CGTI ATTENDEES

Former CEO at BI Fremont and SVP & Global Head of Biotech at Bayer Pharmaceuticals

Jens H. Vogel

Jens H. Vogel, Previous SVP & Global Head of Biotech at Bayer is an advisor of The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025
Dorothee Ambrosius, Head of CMC Strategy Biologicals at Boehringer Ingelheim is an advisor of The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025

Dorothee Ambrosius

Former Head of CMC Strategy Biologicals at Boehringer Ingelheim

Jesse McCool, Co-Founder & CSO of Wheeler Bio is an advisor of The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025

Jesse McCool

CSO of Bionova Scientific & Former CEO at Wheeler Bio

Angela Vollstedt, Global Director, Cell & Gene Therapies Portfolio Manage at Novartis is an advisor of The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025

Angela Vollstedt

Global Director, Cell & Gene Therapies Portfolio Management at Novartis

Uwe Gottschalk, Operating Partner at Keensight Capital is an advisor of The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025

Uwe Gottschalk

Operating Partner at Keensight Capital & Former CSO of Lonza

Paolo Martini, Previous CSO of Moderna speaking at The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025
Two days of powerful talks from CXOs who are pioneering next-generation curative therapies

10th & 11th September 2025
Hyatt Regency Barcelona Tower, Spain

CGTI green logo.

"For the patients, we must do better."

The 8th Annual Cell and Gene Therapy Innovation Summit brings together c-suite, executives, pioneering thinkers and leading academics who are committed to breaking free from traditional silos to evolve and make an impact. Our curated programme is for leaders interested in strategy and innovation. 

Seize this opportunity to experience in person detailed insights and industry best practices. With the rise of automation, digitising, patient centric manufacturing together with the emergence of more regenerative medicine approaching clinical testing and commercialisation, gain knowledge from some of the most renowned leaders driving and shaping the future of Cell and Gene therapy.

GBXEVENTS2024_
GBXEVENTS2024-74_
Learn more

Confirmed Speakers

Learn more

Register Interest

GBXEVENTS2024-168_
Learn more

Programme

GBX Events staff at The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025

The 2025 CGTI programme will focus on solving key scale-up and manufacturing challenges in cell and gene therapies. It will showcase the latest strategies to drive costs down in scale-up, R&D and manufacturing, while exploring new innovations such as automation, AI and advanced technologies. We will also identify how partnerships and navigating the emerging regulatory frameworks can lead to a successful path to commercial viability.

Delegates will have invaluable access to our co-located drug discovery programme #DDIF 2025

 

We are creating moments that matter! 

Picture at The 8th Annual Cell & Gene Therapy Innovation Summit #CGTI which is taking place in the Hyatt Regency Barelona Tower, Spain on the 10th & 11th of September 2025

KEY TOPICS

  • The REGENXBIO Manufacturing Innovation Center – A Strategic Capability for AAV Gene Therapy
    by REGENXBIO

  • The power of resilience: the critical ingredient to moving innovative therapies forward
    by Adverum Biotechnologies

  • The promise of mRNA: a multifunctional platform addressing different therapeutic areas
    by Moderna

#GBXevents

VENDOR FOCUS

  • Patient Centric Manufacturing

  • CDMO 

  • Logistics and supply chain

  • Bioreactor technology

  • Automation and digitalisation

  • Advanced analytical solution

  • Single-use systems

  • Viral vector development & manufacturing services

  • Liquid management systems

#GBXevents

Journey of a CXO 

  • Special presentations from key speakers

  • Thought-provoking lessons learnt and moments worth sharing

  • Discover their journey, their why and the destination of some of the most inspirational CXOs in the industry

  • Understand how and why pitfalls can lead to advances

  • We learn more from our failures rather than our successes

  • These moments are priceless

2025 Programme Snapshot

​SPEAKERS 2025

GBXEVENTS2024-66_

"It's not the destination, it's the journey."

PREVIOUS SPEAKERS